These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 579149)

  • 1. [Mechanisms in inactivating reactive metabolic products of drugs (author's transl)].
    Oesch F
    Arzneimittelforschung; 1977; 27(96):1832-5. PubMed ID: 579149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of genotoxic agents: control of reactive epoxides by hydrolase and transferase reactions.
    Oesch F
    IARC Sci Publ; 1984; (59):73-83. PubMed ID: 6400098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detoxication of the 2',3'-epoxide metabolites of allylbenzene and estragole. Conjugation with glutathione.
    Luo G; Guenthner TM
    Drug Metab Dispos; 1994; 22(5):731-7. PubMed ID: 7835225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epoxide hydrolases are not only a molecular sponge sucking up genotoxic epoxides: new roles in control of blood pressure, inflammation as well as nociception and cell proliferation.
    Hengstler JG; Stewart JD; Bolt HM
    Arch Toxicol; 2009 Apr; 83(4):289-91. PubMed ID: 19333580
    [No Abstract]   [Full Text] [Related]  

  • 5. Estimation of the styrene 7,8-oxide-detoxifying potential of epoxide hydrolase in glutathione-depleted, perfused rat livers.
    Smith BR; Van Anda J; Fouts JR; Bend JR
    J Pharmacol Exp Ther; 1983 Nov; 227(2):491-8. PubMed ID: 6631727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of various enzymes in the control of mutagenic and carcinogenic metabolites derived from aromatic structures.
    Oesch F
    Toxicol Pathol; 1984; 12(4):391-6. PubMed ID: 6398501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of a diol-epoxide and a K-region epoxide with high efficiency by glutathione transferase X.
    Glatt H; Friedberg T; Grover PL; Sims P; Oesch F
    Cancer Res; 1983 Dec; 43(12 Pt 1):5713-7. PubMed ID: 6357430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Species differences in activating and inactivating enzymes related to the control of mutagenic metabolites.
    Oesch F; Raphael D; Schwind H; Glatt HR
    Arch Toxicol; 1977 Dec; 39(1-2):97-108. PubMed ID: 341853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Importance of various enzymes in the control of mutagenic and carcinogenic hydrocarbons].
    Oesch F
    Hautarzt; 1977 Nov; 28(11):563-73. PubMed ID: 599019
    [No Abstract]   [Full Text] [Related]  

  • 10. Search for cell culture systems with diverse xenobiotic-metabolizing activities and their use in toxicological studies.
    Glatt H; Gemperlein I; Turchi G; Heinritz H; Doehmer J; Oesch F
    Mol Toxicol; 1987-1988 Fall; 1(4):313-34. PubMed ID: 3151500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of pulmonary arene oxide biotransformation using the perfused rabbit lung.
    Smith BR; Plummer JL; Ball LM; Bend JR
    Cancer Res; 1980 Jan; 40(1):101-6. PubMed ID: 7349889
    [No Abstract]   [Full Text] [Related]  

  • 12. Mutagenicity and cytotoxicity of benzo(a)pyrene benzo-ring epoxides.
    Wood AW; Wislocki PG; Chang RL; Levin W; Lu AY; Yagi J; Hernandez O; Herina DM; Conney AH
    Cancer Res; 1976 Sep; 36(9 pt.1):3358-66. PubMed ID: 788899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial and mammalian cell mutagenicity of four optically active bay-region 3,4-diol-1,2-epoxides and other derivatives of the nitrogen heterocycle dibenz[c,h]acridine.
    Wood AW; Chang RL; Levin W; Kumar S; Shirai N; Jerina DM; Lehr RE; Conney AH
    Cancer Res; 1986 Jun; 46(6):2760-6. PubMed ID: 3516386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arene imines, a new class of exceptionally potent mutagens in bacterial and mammalian cells.
    Glatt H; Ludewig G; Platt KL; Waechter F; Yona I; Ben-Shoshan S; Jerushalmy P; Blum J; Oesch F
    Cancer Res; 1985 Jun; 45(6):2600-7. PubMed ID: 3921247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammalian epoxide hydrolases in xenobiotic metabolism and signalling.
    Decker M; Arand M; Cronin A
    Arch Toxicol; 2009 Apr; 83(4):297-318. PubMed ID: 19340413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,3-Dichloropropene epoxides: intermediates in bioactivation of the promutagen 1,3-dichloropropene.
    Schneider M; Quistad GB; Casida JE
    Chem Res Toxicol; 1998 Oct; 11(10):1137-44. PubMed ID: 9778309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutagenic and cell-transforming activities of triol-epoxides as compared to other chrysene metabolites.
    Glatt H; Seidel A; Bochnitschek W; Marquardt H; Marquardt H; Hodgson RM; Grover PL; Oesch F
    Cancer Res; 1986 Sep; 46(9):4556-65. PubMed ID: 3524815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enantioselective detoxication of optical isomers of glycidyl ethers.
    Chen R; Nguyen P; You Z; Sinsheimer JE
    Chirality; 1993; 5(7):501-4. PubMed ID: 8240926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of carcinogens, possibilities for modulation.
    Oesch F
    Acta Pharmacol Toxicol (Copenh); 1984; 55 Suppl 2():15-33. PubMed ID: 6385619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimutagenesis by shift in monooxygenase isoenzymes and induction of epoxide hydrolase.
    Oesch F
    Mutat Res; 1988 Dec; 202(2):335-42. PubMed ID: 3057365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.